Literature DB >> 6611388

Predictive value of perfusion defect size using N-isopropyl-(I-123)-p-iodoamphetamine emission tomography in acute stroke.

R G Lee, T C Hill, B L Holman, H D Royal, D H O'Leary, M E Clouse.   

Abstract

Sixteen patients with acute cerebral infarction who were studied with N-isopropyl-I-123-p-iodoamphetamine (IMP) brain scans were followed to determine if the extent of perfusion abnormality was predictive of the clinical course. Lesion size and diminished density on the scans appeared to correlate well with presenting symptoms, but were not predictive of outcome. When evaluated by IMP scanning in conjunction with computerized tomography, however, a group of patients could be identified in whom therapy may improve prognosis.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6611388     DOI: 10.3171/jns.1984.61.3.0449

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  4 in total

1.  SPECT and rehabilitation: which role?

Authors:  U P Guerra
Journal:  Ital J Neurol Sci       Date:  1998-10

2.  Changes in cerebral tissue perfusion during the first 48 hours of ischaemic stroke: relation to clinical outcome.

Authors:  A E Baird; M C Austin; W J McKay; G A Donnan
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-07       Impact factor: 10.154

3.  Evaluation of the significance of "redistribution" in I-123 IMP SPECT in cerebrovascular disorders--a comparative study with PET.

Authors:  M Tsukuda; Y Kuwabara; Y Ichiya; M Otsuka; T Tahara; Y Miyake; M Mizuguchi; R Gunasekera; K Masuda
Journal:  Eur J Nucl Med       Date:  1989

4.  Cerebral-perfusion-based single-photon emission computed tomography (SPECT) staging using NeuroGam® in patients with moyamoya disease.

Authors:  Jai-Hyuck Han; Young Seok Park; Won Hyoung Lee; Sung-Soo Koong; Kyung-Soo Min; Mou-Seop Lee; Young-Gyu Kim; Dong-Ho Kim; Kyung-Sil Yi; Sang-Hoon Cha
Journal:  Childs Nerv Syst       Date:  2015-12-11       Impact factor: 1.475

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.